Chinese english Germany Japanese Korea

Benzoic acid, 4-[(2R,4R)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]-

Benzoic acid, 4-[(2R,4R)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]- Struktur
1644670-39-2
CAS-Nr.
1644670-39-2
Englisch Name:
Benzoic acid, 4-[(2R,4R)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]-
Synonyma:
4-[(2R,4R)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidyl]benzoic acid;Benzoic acid, 4-[(2R,4R)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]-
CBNumber:
CB49935725
Summenformel:
C25H30N2O4
Molgewicht:
422.52
MOL-Datei:
1644670-39-2.mol
Request For Quotation

Benzoic acid, 4-[(2R,4R)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]- Eigenschaften

Siedepunkt:
599.1±50.0 °C(Predicted)
Dichte
1.25±0.1 g/cm3(Predicted)
pka
4.07±0.10(Predicted)

Sicherheit

Benzoic acid, 4-[(2R,4R)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]- Chemische Eigenschaften,Einsatz,Produktion Methoden

Benzoic acid, 4-[(2R,4R)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Benzoic acid, 4-[(2R,4R)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Suzhou ARTK Medchem Co., Ltd. 		+86-512-68323967 +86-18015559028
 sales1@artkmedchem.com China 39009 58
Jiangsu Nanchuang Chemical and Life Health Research Institute Co., Ltd. 025-025-58280381 15720605021
 zhang_lei@jsnchem.com China 1515 58
PharmaBlock Sciences (Nanjing), Inc. 4000255188
 sun_dan@PharmaBlock.com China 7268 58
  • Benzoic acid, 4-[(2R,4R)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]-
  • 4-[(2R,4R)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidyl]benzoic acid
  • 1644670-39-2
Copyright 2019 © ChemicalBook. All rights reserved